The researchers, led by Jonas Blomberg of the Department of Medical Sciences at Uppsala University, developed a new probe to target the highly variable influenza A target sequence. The probe, called MegaBeacon, is described as a "hybrid" between a molecular beacon and a TaqMan probe.